MedPath
HSA Approval

MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG

SIN14954P

MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG

MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG

February 19, 2016

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence HolderMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, CHEWABLE

ORAL

Medical Information

R03DC03

montelukast

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Hetero Labs Limited

Active Ingredients

Montelukast Sodium 4.160 mg eqv Montelukast

4.000 mg

Montelukast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MONAST 4 MONTELUKAST SODIUM PAEDIATRIC CHEWABLE TABLET 4MG - HSA Approval | MedPath